133 related articles for article (PubMed ID: 6120500)
1. Vascular aspects of calcium antagonists.
Van Zwieten PA; Van Meel JC; Timmermans PB
Pharm Weekbl Sci; 1981 Dec; 3(6):237-47. PubMed ID: 6120500
[TBL] [Abstract][Full Text] [Related]
2. [Interaction between calcium inhibitors and vascular alpha-adrenergic receptors].
van Zwieten PA; Timmermans PB
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():7-13. PubMed ID: 3004370
[TBL] [Abstract][Full Text] [Related]
3. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.
van Zwieten PA; van Meel JC; Timmermans PB
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S273-9. PubMed ID: 6184552
[TBL] [Abstract][Full Text] [Related]
4. [Interaction between calcium antagonists and vascular postsynaptic alpha-receptors].
van Meel JC; Timmermans PB; van Zwieten PA
J Pharmacol; 1982; 13(3):367-79. PubMed ID: 6290792
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Hypertension; 1983; 5(4 Pt 2):II8-17. PubMed ID: 6134673
[TBL] [Abstract][Full Text] [Related]
6. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological basis for use of calcium channel antagonists in hypertension.
Scriabine A; Kazda S; Garthoff B; Nickerson PA
Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
[TBL] [Abstract][Full Text] [Related]
11. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
Lee JY; DeBernardis JF
Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
[TBL] [Abstract][Full Text] [Related]
12. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
Busse R; Bassenge E
Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Circ Res; 1983 Feb; 52(2 Pt 2):I77-80. PubMed ID: 6299607
[No Abstract] [Full Text] [Related]
14. [Calcium antagonists: sites of action, pharmacologic effect profile and clinical use. 2: Pharmacologic effects, indications and side effects of calcium antagonists].
Bluth R; Langnickel R
Z Arztl Fortbild (Jena); 1986; 80(6):237-40. PubMed ID: 2424182
[No Abstract] [Full Text] [Related]
15. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological basis of the antihypertensive action of calcium entry blockers.
van Zwieten PA; Timmermans PB
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S11-7. PubMed ID: 2412005
[TBL] [Abstract][Full Text] [Related]
17. [Calcium, calcium antagonists and cerebral circulation].
Beketov AI; Gromova TM
Farmakol Toksikol; 1988; 51(2):103-7. PubMed ID: 2454201
[No Abstract] [Full Text] [Related]
18. Calcium antagonism: a new approach.
Nayler WG
Clin Exp Pharmacol Physiol Suppl; 1982; 6():3-13. PubMed ID: 6288293
[TBL] [Abstract][Full Text] [Related]
19. [Specific mechanism of action of calcium antagonists in the neutralization of experimental coronary spasms].
Fleckenstein-Grün G; Makita YJ; Byon YK; Frey M
Z Kardiol; 1984; 73 Suppl 2():71-7. PubMed ID: 6099011
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action of calcium antagonists in the treatment of vascular diseases].
Mayerhofer S
Wien Med Wochenschr; 1986 Nov; 136(21-22):591-4. PubMed ID: 2435066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
